An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns
- PMID: 35835229
- DOI: 10.1016/j.jpeds.2022.07.003
An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns
Abstract
Objective: To establish a reference nomogram for end-tidal CO corrected for ambient CO (ETCOc) levels in term and late-preterm Chinese newborns and then assess its efficacy to identify hemolytic hyperbilirubinemia.
Study design: We conducted a prospective study by measuring concurrent ETCOc and total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) levels collected postnatally at 12, 24, 48, 72, 96, and 120 hours of age. ETCOc at the 25th, 50th, 75th, and 95th percentiles at each epoch were used to construct the reference nomogram. We then explored the ability of predischarge ETCOc and TSB/TcB metrics to predict the development of hyperbilirubinemia requiring phototherapy in early postnatal period and jaundice readmission in late postnatal period.
Results: Our nomogram, based on 990 measurements from 455 infants who were not nonhemolytic, displayed a steady line within 3 postnatal days, followed by a subsequent decline. From a cohort of infants with a serial ETCOc measurements (n = 130) and those readmitted (n = 21), we found that ETCOc and TSB/TcB ≥75th percentile can identify most hemolytic hyperbilirubinemia between 12 and 72 hours after birth with an area under the curve (AUC) of 0.741. An ETCOc ≥1.7 ppm alone between 96 and 120 hours after birth can identify most hemolytic hyperbilirubinemia with an AUC of 0.816. In addition, 90.5% of readmitted infants had an ETCOc ≥75th percentile.
Conclusions: An ETCOc reference nomogram during the first 5 postnatal days in nonhemolytic term and late-preterm newborns can be used to identify hemolytic hyperbilirubinemia requiring phototherapy in the early postnatal period and readmission in the late postnatal period.
Keywords: bilirubin production; end-tidal carbon monoxide; hemolysis; hyperbilirubinemia; nomogram.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
End-tidal CO corrected for ambient CO risk adjusted phototherapy threshold for the management of neonatal hyperbilirubinemia: a randomized clinical trial.World J Pediatr. 2025 Aug;21(8):792-799. doi: 10.1007/s12519-025-00954-y. Epub 2025 Aug 4. World J Pediatr. 2025. PMID: 40758202 Free PMC article. Clinical Trial.
-
Identification of risk for neonatal haemolysis.Acta Paediatr. 2018 Aug;107(8):1350-1356. doi: 10.1111/apa.14316. Epub 2018 Apr 16. Acta Paediatr. 2018. PMID: 29532503
-
Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia.Acta Paediatr. 2016 May;105(5):e189-94. doi: 10.1111/apa.13341. Epub 2016 Feb 29. Acta Paediatr. 2016. PMID: 26802319 Clinical Trial.
-
End-tidal carbon monoxide and hemolysis.J Perinatol. 2014 Aug;34(8):577-81. doi: 10.1038/jp.2014.66. Epub 2014 Apr 17. J Perinatol. 2014. PMID: 24743136 Review.
-
Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.Semin Perinatol. 2021 Feb;45(1):151351. doi: 10.1016/j.semperi.2020.151351. Epub 2020 Dec 1. Semin Perinatol. 2021. PMID: 33308896 Review.
Cited by
-
Erythrokinetic mechanism(s) causing the "late anemia" of hemolytic disease of the fetus and newborn.J Perinatol. 2024 Jun;44(6):916-919. doi: 10.1038/s41372-024-01872-z. Epub 2024 Jan 12. J Perinatol. 2024. PMID: 38216678 Review.
-
End-tidal CO corrected for ambient CO risk adjusted phototherapy threshold for the management of neonatal hyperbilirubinemia: a randomized clinical trial.World J Pediatr. 2025 Aug;21(8):792-799. doi: 10.1007/s12519-025-00954-y. Epub 2025 Aug 4. World J Pediatr. 2025. PMID: 40758202 Free PMC article. Clinical Trial.
-
End-tidal carbon monoxide for routine monitoring of significant hemolysis in the management of newborn hyperbilirubinemia.J Perinatol. 2025 Jul;45(7):957-960. doi: 10.1038/s41372-025-02242-z. Epub 2025 Feb 26. J Perinatol. 2025. PMID: 40011553 Free PMC article.
-
A "Gold Standard" Test for Diagnosing and Quantifying Hemolysis in Neonates and Infants.J Perinatol. 2023 Dec;43(12):1541-1547. doi: 10.1038/s41372-023-01730-4. Epub 2023 Jul 19. J Perinatol. 2023. PMID: 37468612 Review.
-
End-tidal carbon monoxide concentrations measured within 48 hours of birth predict hemolytic hyperbilirubinemia.J Perinatol. 2024 Jun;44(6):897-901. doi: 10.1038/s41372-024-01967-7. Epub 2024 Apr 16. J Perinatol. 2024. PMID: 38627593
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources